ResearcherMayo ClinicActive in the last 2 years
Danielle Marie Carlson
Matched on ORCID iD 0009-0001-2113-429X; OpenAlex author ID A5034264949. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2024: 1 paper · 2025: 2 papers
Papers 3
- Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer. Co-author DOI 10.1136/gutjnl-2024-334374↗
- Molecular KRAS ctDNA Predicts Metastases and Survival in Pancreatic Cancer: A Prospective Cohort Study. Co-author DOI 10.1245/s10434-025-17036-y↗
- Baseline Characteristics and Use of Pretherapeutic 18 F-Fluorodeoxyglucose-PET for Pancreatic Cancer. Co-author DOI 10.1097/xcs.0000000000001059↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Amro M. Abdelrahman · 3 shared papers, 2024–2025 · strength 0.59
- Paper Baseline Characteristics and Use of Pretherapeutic 18 F-Fluorodeoxyglucose-PET for Pancreatic Cancer. DOI 10.1097/xcs.0000000000001059↗
- Paper Molecular KRAS ctDNA Predicts Metastases and Survival in Pancreatic Cancer: A Prospective Cohort Study. DOI 10.1245/s10434-025-17036-y↗
- Paper Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identit… DOI 10.1136/gutjnl-2024-334374↗
- Mark Joseph Truty · 3 shared papers, 2024–2025 · strength 0.59
- Paper Baseline Characteristics and Use of Pretherapeutic 18 F-Fluorodeoxyglucose-PET for Pancreatic Cancer. DOI 10.1097/xcs.0000000000001059↗
- Paper Molecular KRAS ctDNA Predicts Metastases and Survival in Pancreatic Cancer: A Prospective Cohort Study. DOI 10.1245/s10434-025-17036-y↗
- Paper Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identit… DOI 10.1136/gutjnl-2024-334374↗
- Aashna Karbhari · 1 shared paper, 2024 · strength 0.21
- Ajit Harishkumar Goenka · 1 shared paper, 2024 · strength 0.21
- Jennifer A. Yonkus · 1 shared paper, 2025 · strength 0.20
- Sean Patrick Cleary · 1 shared paper, 2025 · strength 0.20
- Jennifer L. Leiting · 1 shared paper, 2025 · strength 0.20
- Travis Edward Grotz · 1 shared paper, 2025 · strength 0.20
- Roberto Alva‐Ruiz · 1 shared paper, 2025 · strength 0.20
- Susanne Gray Warner · 1 shared paper, 2025 · strength 0.20
- Michael L. Kendrick · 1 shared paper, 2025 · strength 0.20
- Cornelius A. Thiels · 1 shared paper, 2025 · strength 0.20
- Ryan Michael Carr · 1 shared paper, 2025 · strength 0.20
- Robert R. McWilliams · 1 shared paper, 2025 · strength 0.20
- Christina Parassiadis · 1 shared paper, 2025 · strength 0.19
- Xin Wang · 1 shared paper, 2025 · strength 0.19
- Jochen Gaedcke · 1 shared paper, 2025 · strength 0.19
- Ana P. Kutschat · 1 shared paper, 2025 · strength 0.19
- Thomas L. Ekstrom · 1 shared paper, 2025 · strength 0.19
- Steven A. Johnsen · 1 shared paper, 2025 · strength 0.19
- Zeynab Najafova · 1 shared paper, 2025 · strength 0.19
- Elisabeth Heßmann · 1 shared paper, 2025 · strength 0.19
- Volker Ellenrieder · 1 shared paper, 2025 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.